Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Harbor MedTech
About
Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more.It offers NeuvoCell, a wound therapy for chronic wounds, such as diabetic, venous, and pressure ulcers; products for hernia and joint repair, orthopedic soft tissue repair, breast reconstruction, and urogynecological repair; and Architect, a collagen matrix for treatment of partial and full-thickness skin wounds. Harbor MedTech, Inc. has a strategic partnership with Edwards Lifesciences.The company was founded in 2010 by Jim Jungwirth and Keith Myers and is based in Irvine, California.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 5, 2017 | Series C | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
